| Cover and Content | |
| 1-4 |
| Cost-Effectiveness Analysis Of The Prevention And Treatment Of Cytomegalovirus (CMV) Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults | |
| Toni Vekov, Anna Gavrilova, Nadia Veleva, Jivko Kolev | 5-10 |
| Questionnaire Survey Among Hospital Pharmacists On The Effects Of The Change In The Legislation Regulating Clinical Trials In Bulgaria | |
| Liliya Bogdanova, Evgeni Grigorov, Valentina Belcheva, Ilko Getov | 11-18 |
| Implementation of central preparation of cytostatics in Bulgaria | |
| Velina Grigorova, Tsvetelina Stefanova, Evgeni Grigorov | 19-23 |
| Historical Review And Analysis Of Contemporary Aspects In The Treatment Of Acute And Chronic Form Of Q-Fever | |
| Metodi Kunchev, Ivanka Gergova, Virsavia Vaseva, Evgeni Grigorov | 24-34 |
| Curcumin‘s Therapeutic Potential | |
| Kaloyan Kaloyanov, Maya Yotova, Georgi Momekov, Spiro Konstantinov | 35-39 |
| Endometriosis - Review Of Current Therapeutic Aproaches For Disease Control | |
| Victoria Spasova, Vesela Karamisheva, Rada Staneva, Savina Hadjidekova, Olga Antonova, Liliya Koleva, Draga Toncheva | 40-50 |
| Overview of regulation and quality aspects of conducting clinical trials and medicinal product use in real-life practice | |
| Violeta Getova | 51-59 |
| Potential Drug-Drug Interactions With Tyrosine Kinase Inhibitors | |
| Radeva-Ilieva Maya, Bogdan Kirilov, Kaloyan Georgiev | 60-67 |
| Incorrect storage of medicines and potential for cost savings | |
| Lene Colberg, Lone Schmidt-Petersen, Merete Kock Hansen, Brigitte Smolsky Larsen, Sigrid Otnes | 68-72 |
| Impact of the council of europe resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients | |
| H P A Scheepers, V Neerup Handlos, S Walser, M D B Schutjens, C Neef | 73-82 |